GB0515430D0 - Preparation of cabergoline - Google Patents

Preparation of cabergoline

Info

Publication number
GB0515430D0
GB0515430D0 GBGB0515430.7A GB0515430A GB0515430D0 GB 0515430 D0 GB0515430 D0 GB 0515430D0 GB 0515430 A GB0515430 A GB 0515430A GB 0515430 D0 GB0515430 D0 GB 0515430D0
Authority
GB
United Kingdom
Prior art keywords
cabergoline
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0515430.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resolution Chemicals Ltd
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Priority to GBGB0515430.7A priority Critical patent/GB0515430D0/en
Publication of GB0515430D0 publication Critical patent/GB0515430D0/en
Priority to US11/268,118 priority patent/US7339060B2/en
Priority to JP2008502478A priority patent/JP2008534484A/en
Priority to EP09170766A priority patent/EP2135869A1/en
Priority to EP06726488A priority patent/EP1861398A2/en
Priority to CA002602898A priority patent/CA2602898A1/en
Priority to NZ561073A priority patent/NZ561073A/en
Priority to AU2006226135A priority patent/AU2006226135A1/en
Priority to BRPI0609425-2A priority patent/BRPI0609425A2/en
Priority to PCT/GB2006/001068 priority patent/WO2006100492A2/en
Priority to CA002616738A priority patent/CA2616738A1/en
Priority to CNA200680027137XA priority patent/CN101228159A/en
Priority to JP2008523446A priority patent/JP2009502895A/en
Priority to ZA200801151A priority patent/ZA200801151B/en
Priority to EP06765107A priority patent/EP1912984A1/en
Priority to AU2006273831A priority patent/AU2006273831A1/en
Priority to PCT/GB2006/002784 priority patent/WO2007012846A1/en
Priority to IL185600A priority patent/IL185600A0/en
Priority to NO20074758A priority patent/NO20074758L/en
Priority to IL188598A priority patent/IL188598A0/en
Priority to NO20080461A priority patent/NO20080461L/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
GBGB0515430.7A 2005-03-23 2005-07-27 Preparation of cabergoline Ceased GB0515430D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB0515430.7A GB0515430D0 (en) 2005-07-27 2005-07-27 Preparation of cabergoline
US11/268,118 US7339060B2 (en) 2005-03-23 2005-11-07 Preparation of cabergoline
JP2008502478A JP2008534484A (en) 2005-03-23 2006-03-23 Production of cabergoline
EP09170766A EP2135869A1 (en) 2005-03-23 2006-03-23 Preparation of a crystalline form of cabergoline
EP06726488A EP1861398A2 (en) 2005-03-23 2006-03-23 Preparation of cabergoline
CA002602898A CA2602898A1 (en) 2005-03-23 2006-03-23 Preparation of cabergoline
NZ561073A NZ561073A (en) 2005-03-23 2006-03-23 Preparation of cabergoline polymorph
AU2006226135A AU2006226135A1 (en) 2005-03-23 2006-03-23 Preparation of cabergoline
BRPI0609425-2A BRPI0609425A2 (en) 2005-03-23 2006-03-23 cabergoline preparation
PCT/GB2006/001068 WO2006100492A2 (en) 2005-03-23 2006-03-23 Preparation of cabergoline
PCT/GB2006/002784 WO2007012846A1 (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline form i
CA002616738A CA2616738A1 (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline form i
CNA200680027137XA CN101228159A (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline form i
JP2008523446A JP2009502895A (en) 2005-07-27 2006-07-27 Preparation of cabergoline solvates and cabergoline form I
ZA200801151A ZA200801151B (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline Form 1
EP06765107A EP1912984A1 (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline form i
AU2006273831A AU2006273831A1 (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline Form I
IL185600A IL185600A0 (en) 2005-03-23 2007-08-30 A method for preparing cabergoline
NO20074758A NO20074758L (en) 2005-03-23 2007-09-18 Manufacture of cabergoline
IL188598A IL188598A0 (en) 2005-07-27 2008-01-06 A solvate of cabergoline and methods of preparing cabergoline form 1 utilizing the same
NO20080461A NO20080461L (en) 2005-07-27 2008-01-24 Solvent of cabergoline and preparations of cobergoline form I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0515430.7A GB0515430D0 (en) 2005-07-27 2005-07-27 Preparation of cabergoline

Publications (1)

Publication Number Publication Date
GB0515430D0 true GB0515430D0 (en) 2005-08-31

Family

ID=34976701

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0515430.7A Ceased GB0515430D0 (en) 2005-03-23 2005-07-27 Preparation of cabergoline

Country Status (10)

Country Link
EP (1) EP1912984A1 (en)
JP (1) JP2009502895A (en)
CN (1) CN101228159A (en)
AU (1) AU2006273831A1 (en)
CA (1) CA2616738A1 (en)
GB (1) GB0515430D0 (en)
IL (1) IL188598A0 (en)
NO (1) NO20080461L (en)
WO (1) WO2007012846A1 (en)
ZA (1) ZA200801151B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
CN104147041B (en) * 2014-08-17 2017-02-22 山西振东安特生物制药有限公司 Dispersion preparation containing colloidal bismuth pectin and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
AU2003224665A1 (en) * 2002-03-15 2003-09-29 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
BR0308304A (en) * 2002-03-15 2004-12-28 Pharmacia Corp Process for preparing crystalline cabergoline form I
WO2004101510A2 (en) * 2003-05-08 2004-11-25 Ivax Corporation Polymorphs of cabergoline

Also Published As

Publication number Publication date
JP2009502895A (en) 2009-01-29
EP1912984A1 (en) 2008-04-23
CA2616738A1 (en) 2007-02-01
WO2007012846A1 (en) 2007-02-01
CN101228159A (en) 2008-07-23
ZA200801151B (en) 2009-04-29
AU2006273831A1 (en) 2007-02-01
IL188598A0 (en) 2008-04-13
NO20080461L (en) 2008-04-18

Similar Documents

Publication Publication Date Title
HRP20150012T1 (en) 39-desmethoxy derivatives of rapamycin
PT1802579E (en) Derivatives of 3-arylaminopyridine
ZA200710877B (en) Preparation of syngas
IL184036A0 (en) Preparation of rosuvastatin
EP1976609A4 (en) Preparation of biomolecules
IL191774A0 (en) Solid preparation
IL185757A0 (en) Methods of decreasing calcifcation
EP1897558A4 (en) Solid preparation
GB0421149D0 (en) Preparation of oxycodone
EP1838906A4 (en) Preparation of suspensions
EP1893625A4 (en) Methods for the preparation of 9-deazapurine derivatives
EP1912499A4 (en) Preparation of montelukast
HK1122797A1 (en) Derivatives of pyrido
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1938808A4 (en) Preparation for external use
IL187407A0 (en) Sugar-coated preparation
EP1964538A4 (en) Preparation method of pharmaceutials
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
EP1931370A4 (en) Use of des-aspartate-angiotensin i
GB0515430D0 (en) Preparation of cabergoline
GB0505965D0 (en) Preparation of cabergoline
GB0409250D0 (en) Preparation of cabergoline
GB0508439D0 (en) Design of structural elements
HU0500461D0 (en) Pyperazinyl derivatives of alkyl-oxindoles
PL381715A1 (en) New piperazinic derivatives of dialkyloxindole

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)